Investigate the Contribution of Ipatasertib to Neoadjuvant Chemotherapy Plus Atezolizumab in TNBC
Clinical trial NCT05498896 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05498896
- Sponsor
- Queen Mary University of London
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-19
- Primary completion
- 2026-08-31
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.